PUMA 抗体
(BCL2 Binding Component 3 (BBC3))
This gene encodes a member of the BCL-2 family of proteins. This family member belongs to the BH3-only pro-apoptotic subclass. The protein cooperates with direct activator proteins to induce mitochondrial outer membrane permeabilization and apoptosis. It can bind to anti-apoptotic Bcl-2 family members to induce mitochondrial dysfunction and caspase activation. Because of its pro-apoptotic role, this gene is a potential drug target for cancer therapy and for tissue injury. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| PUMA 抗体 (C-Term) (Sepharose) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 (AA 76-170) | 人, 大鼠, 小鼠 | 小鼠 Monoclonal |
|
|
|
| PUMA 抗体 (AA 76-170) | 人, 大鼠 | 小鼠 Monoclonal |
|
|
|
| Recombinant PUMA 抗体 | 人 | 兔 Monoclonal |
|
|
|
| PUMA 抗体 (N-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 (AA 76-170) | 人, 大鼠, 小鼠 | 小鼠 Monoclonal |
|
|
|
| PUMA 抗体 (AA 76-170) | 人, 大鼠 | 小鼠 Monoclonal |
|
|
|
| PUMA 抗体 (C-Term) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 (N-Term) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 (C-Term) (Biotin) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 (N-Term) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 (C-Term) (HRP) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 | 人, 大鼠, 小鼠 | 兔 Monoclonal |
|
|
|
| PUMA 抗体 (N-Term) (Fluoro594) | 人 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 (C-Term) (Fluoro594) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 (C-Term) (Fluoro550) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 (N-Term) (Fluoro550) | 人 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 (C-Term) (APC) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| PUMA 抗体 (N-Term) (APC) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Sepharose
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2A9G5
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 76-170
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2A8F6
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 76-170
Primary Antibody
- WB (Western Blotting: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- EIA (Enzyme Immunoassay: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2A9G5
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 76-170
Primary Antibody
- WB (Western Blotting: 有验证图片)
- EIA (Enzyme Immunoassay: 所列应用)
- 适用
- 人, 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2A8F6
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 76-170
Primary Antibody
- WB (Western Blotting: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro594
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro594
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Latest Publications for our PUMA 抗体
: "Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation." in: Cancer cell, Vol. 35, Issue 2, pp. 191-203.e8, (2019) (PubMed).
: "Temporal and differential regulation of KAISO-controlled transcription by phosphorylated and acetylated p53 highlights a crucial regulatory role of apoptosis." in: The Journal of biological chemistry, Vol. 294, Issue 35, pp. 12957-12974, (2019) (PubMed).
: "Inhibition of REST Suppresses Proliferation and Migration in Glioblastoma Cells." in: International journal of molecular sciences, Vol. 17, Issue 5, (2017) (PubMed).
: "Paradoxical Roles of Elongation Factor-2 Kinase in Stem Cell Survival." in: The Journal of biological chemistry, Vol. 291, Issue 37, pp. 19545-57, (2016) (PubMed).
: "Anticancer bioactive peptides suppress human colorectal tumor cell growth and induce apoptosis via modulating the PARP-p53-Mcl-1 signaling pathway." in: Acta pharmacologica Sinica, Vol. 36, Issue 12, pp. 1514-9, (2016) (PubMed).
: "Detection of Bim and Puma in mouse hair follicles using immunofluorescence and TUNEL assay double staining." in: Biotechnic & histochemistry : official publication of the Biological Stain Commission, pp. 1-7, (2015) (PubMed).
: "p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death." in: Oncogene, (2015) (PubMed).
: "Nerve growth factor reduces apoptotic cell death in rat facial motor neurons after facial nerve injury." in: Neurosciences (Riyadh, Saudi Arabia), Vol. 20, Issue 1, pp. 65-8, (2015) (PubMed).
: "A small peptide derived from p53 linker region can resume the apoptotic activity of p53 by sequestering iASPP with p53." in: Cancer letters, Vol. 356, Issue 2 Pt B, pp. 910-7, (2014) (PubMed).
: "The BH3 mimetic ABT-263 synergizes with the MEK1/2 inhibitor selumetinib/AZD6244 to promote BIM-dependent tumour cell death and inhibit acquired resistance." in: The Biochemical journal, Vol. 450, Issue 2, pp. 285-94, (2013) (PubMed).
: "Temporal and differential regulation of KAISO-controlled transcription by phosphorylated and acetylated p53 highlights a crucial regulatory role of apoptosis." in: The Journal of biological chemistry, Vol. 294, Issue 35, pp. 12957-12974, (2019) (PubMed).
: "Inhibition of REST Suppresses Proliferation and Migration in Glioblastoma Cells." in: International journal of molecular sciences, Vol. 17, Issue 5, (2017) (PubMed).
: "Paradoxical Roles of Elongation Factor-2 Kinase in Stem Cell Survival." in: The Journal of biological chemistry, Vol. 291, Issue 37, pp. 19545-57, (2016) (PubMed).
: "Anticancer bioactive peptides suppress human colorectal tumor cell growth and induce apoptosis via modulating the PARP-p53-Mcl-1 signaling pathway." in: Acta pharmacologica Sinica, Vol. 36, Issue 12, pp. 1514-9, (2016) (PubMed).
: "Detection of Bim and Puma in mouse hair follicles using immunofluorescence and TUNEL assay double staining." in: Biotechnic & histochemistry : official publication of the Biological Stain Commission, pp. 1-7, (2015) (PubMed).
: "p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death." in: Oncogene, (2015) (PubMed).
: "Nerve growth factor reduces apoptotic cell death in rat facial motor neurons after facial nerve injury." in: Neurosciences (Riyadh, Saudi Arabia), Vol. 20, Issue 1, pp. 65-8, (2015) (PubMed).
: "A small peptide derived from p53 linker region can resume the apoptotic activity of p53 by sequestering iASPP with p53." in: Cancer letters, Vol. 356, Issue 2 Pt B, pp. 910-7, (2014) (PubMed).
: "The BH3 mimetic ABT-263 synergizes with the MEK1/2 inhibitor selumetinib/AZD6244 to promote BIM-dependent tumour cell death and inhibit acquired resistance." in: The Biochemical journal, Vol. 450, Issue 2, pp. 285-94, (2013) (PubMed).
Aliases for PUMA 抗体
BCL2 binding component 3 (BBC3) 抗体Bcl-2 binding component 3 (Bbc3) 抗体
BCL2 binding component 3 (Bbc3) 抗体
BCL2 binding component 3 (bbc3) 抗体
BBC3 抗体
JFY-1 抗体
JFY1 抗体
Puma 抗体
PUMA 抗体
PUMA/JFY1 抗体
您还需要查找其他产品吗？
- PUM2 抗体
- PUM1 抗体
- PTX4 抗体
- PTX3 抗体
- PTTG1IP 抗体
- PTTG1 抗体
- PTS 抗体
- PTRHD1 抗体
- PTRH2 抗体
- PTRF 抗体
- PTPRZ1 抗体
- PTPRU 抗体
- PTPRT 抗体
- PTPRS 抗体
- PTPRR 抗体
- PTPRQ 抗体
- PTPRO 抗体
- PTPRN2 抗体
- PTPRN 抗体
- PTPRM 抗体
- PURA 抗体
- Purine Nucleoside Phosphorylase 抗体
- Purine-Rich Element Binding Protein B 抗体
- Purinergic Receptor P2x, Ligand-Gated Ion Channel, 3 抗体
- Purinergic Receptor P2Y, G-Protein Coupled, 13 抗体
- PUS1 抗体
- PUS10 抗体
- PUS3 抗体
- PUSL1 抗体
- PVRIG 抗体
- PVRL1 抗体
- PVRL2 抗体
- PVRL3 抗体
- PVRL4 抗体
- PWP1 抗体
- PXK 抗体
- PXMP2 抗体
- PYCARD 抗体
- PYCR1 抗体
- PYCR2 抗体
You are here:
